Poor Patient Follow-up After Metal-on-Metal Total Hip Arthroplasty.

Routine follow-up approximately every 2 to 5 years after total hip arthroplasty (THA) is a common practice. However, although patients are informed of the importance of follow-up, our mean follow-up rate for patients after standard non-metal-on-metal (MOM) THA is only 19%. The US Food and Drug Administration has released several statements on the importance of follow-up every 2 years after MOM THA. With the potential risks of MOM THA apparently widely known, we report on our ability to obtain timely follow-up at 2 separate centers. Two separate centers performed 570 MOM THA procedures between 2002 and 2010. An attempt was made to reach every patient by either telephone or letter to obtain ion levels, radiographs, and examinations. Repeat telephone calls and/or letters to those not reached were made annually. Patients were told of the unique importance of follow-up at each contact. Of the patients, 43% had not been seen within the past 5 years, and only 26% had been seen within the past 2 years. Only 61% had their first measurement of ion levels, and only 30% of patients had a second set of measurement of ion levels. A total of 48 revisions occurred in this group, and 36 patients died. Despite the apparent widespread dissemination of information regarding the potential risks of MOM THA and concerted efforts to contact patients for follow-up, we have been able to achieve a follow-up rate of only 26%. This rate is only marginally better than the mean follow-up for non-MOM THA in our practices. The implications of this poor follow-up are unknown. [Orthopedics. 2022;45(4):e196-e200.].

Average narcotic usage in a group of TKA patients following a modern TKA protocol.

INTRODUCTION: The optimal dosing of post-operative total knee arthroplasty (TKA) narcotics is unclear. We report on the average narcotic usage in a group of patients treated with an identical multimodal pain protocol following TKA. MATERIALS AND METHODS: 49 patients undergoing TKA participated in the survey. Patients with pre-op narcotic use, recent prior total joint arthroplasty or study refusal were excluded. All patients received a spinal anesthetic. No pre-surgery narcotics were given. All received an identical local infiltrative anesthetic combination along with a multimodal pain protocol. Patients were placed into an identical rapid rehab program. Narcotic usage during hospitalization was recorded in morphine equivalent doses (MED). Patients were given a journal to record their daily narcotic utilization. RESULTS: Pre-operative pain scores of the excluded groups had slightly higher but clinically insignificant differences compared to the study group. In the hospital, POD1 study group daily MED averaged 28 (range 0-110). POD2 had an average of 33.6 and POD 3 daily usages averaged 28.6 (range 0-100). By the end of week two, the average daily use was 19.2 and 24% patients were off all narcotics. By the end of week four, the average daily usage was 7.5 and 63% of patients were off all narcotics. By 8 weeks, there were no patients still taking narcotics. KSS averaged 76.9 (range 51-97) at the 6 week visit, and 94.2 at the 3-month visit (range 72-100). SUMMARY: This study documents the average needs of an average TKA patient treated with modern pain protocols. The majority of these patients were off narcotics by week four.

Ignore the Patella in Revision Total Knee Surgery: A Minimum 5-Year Follow-Up With Patella Component Retention.

BACKGROUND: In the setting of aseptic revision, a common question is: what should be done with the previously resurfaced patella? We report on a series of aseptic revision total knee arthroplasties (RTKA) where one or both components were revised and the patella was not. METHODS: The study group was 147 consecutive RTKA in 137 patients with a mean age of 70.1 ± 9.3 years where the patella was not revised. The average body mass index was 31.0 ± 5.4 kg/m2. Follow-up was a minimum of 5 years (range, 5 to 12 years). At final follow-up, 13 patients died and 2 patients were lost to follow-up leaving 122 patients and 130 knees available for review. Mean time from primary surgery to RTKA was 9.2 ± 5.5 years. Both components were revised in 50 knees, the femur only in 11 knees, the tibia only in 12 knees, and 57 had an isolated polyethylene revision. We found 5 patients with a mismatch between the patella and femoral components and 30 cases with patella component wear identified intraoperatively. RESULTS: At final follow-up, there were no reoperations on any patella and none were at risk of failure. There were 6 knees with a lateral patella tilt beyond 10°, but none were subluxed. Knee Society Scores averaged 85 ± 17.2 points at final follow-up. CONCLUSION: At midterm follow-up in this group of RTKA where the patella was not revised, we identified no subsequent failures of the patella. This is despite the presence of mild patella polyethylene wear and mismatched shapes in several knees. LEVEL OF EVIDENCE: III.